[
  {
    "ts": null,
    "headline": "2025 Dividend Kings - Off To A Strong Start",
    "summary": "The Dividend Kings are outperforming the S&P 500 in 2025, up 4% YTD versus 1.39% for SPY. Check out the list of dividend kings that are attractive.",
    "url": "https://finnhub.io/api/news?id=4d1ad04ba319cc3c5b9725d0c00fcd5010cc3a8675291277e8fe0612340cb75c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740596821,
      "headline": "2025 Dividend Kings - Off To A Strong Start",
      "id": 132886166,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148947552/image_2148947552.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "The Dividend Kings are outperforming the S&P 500 in 2025, up 4% YTD versus 1.39% for SPY. Check out the list of dividend kings that are attractive.",
      "url": "https://finnhub.io/api/news?id=4d1ad04ba319cc3c5b9725d0c00fcd5010cc3a8675291277e8fe0612340cb75c"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference",
    "summary": "NORTH CHICAGO, Ill., Feb. 26, 2025 /PRNewswire/ -- AbbVie will participate in the TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, 2025. Management will participate in a fireside...",
    "url": "https://finnhub.io/api/news?id=5e1015bda8d5375e90e45db07a78fb679697f2e82278ef26c1413a573a4c1f5c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740556871,
      "headline": "AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference",
      "id": 132877833,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "NORTH CHICAGO, Ill., Feb. 26, 2025 /PRNewswire/ -- AbbVie will participate in the TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, 2025. Management will participate in a fireside...",
      "url": "https://finnhub.io/api/news?id=5e1015bda8d5375e90e45db07a78fb679697f2e82278ef26c1413a573a4c1f5c"
    }
  },
  {
    "ts": null,
    "headline": "Miller-Howard Income-Equity Q4 2024 Commentary",
    "summary": "Both versions of Miller-Howard Income-Equity outperformed the Russell 1000 Value Index for the fourth quarter and for 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=2b3602619dd9439e98f6576dac3d46b062c9d1a5dae95b3aaee3c4a3c5d4f012",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740548700,
      "headline": "Miller-Howard Income-Equity Q4 2024 Commentary",
      "id": 132877054,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2167331445/image_2167331445.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Both versions of Miller-Howard Income-Equity outperformed the Russell 1000 Value Index for the fourth quarter and for 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=2b3602619dd9439e98f6576dac3d46b062c9d1a5dae95b3aaee3c4a3c5d4f012"
    }
  }
]